Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease

[1]  Undurti N. Das,et al.  Brain-derived neurotrophic factor and its clinical implications , 2015, Archives of medical science : AMS.

[2]  J. Montaner,et al.  Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9* , 2015, The Journal of Biological Chemistry.

[3]  E. Tsilibary,et al.  Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice , 2014, Neurobiology of Disease.

[4]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[5]  G. Breen,et al.  Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway , 2012, Molecular Psychiatry.

[6]  F. D. Felice.  Alzheimer’s disease and insulin resistance: translating basic science into clinical applications , 2013 .

[7]  Jyothi Arikkath,et al.  Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex , 2012, Nature Protocols.

[8]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[9]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[10]  E. Tsilibary,et al.  Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over‐expressing MMP9 , 2012, Journal of neurochemistry.

[11]  E. Feldman,et al.  Insulin resistance in the nervous system , 2012, Trends in Endocrinology & Metabolism.

[12]  P. Moreira,et al.  Insulin in Central Nervous System: More than Just a Peripheral Hormone , 2012, Journal of aging research.

[13]  B. Allinquant,et al.  Functions of Aβ, sAPPα and sAPPβ : similarities and differences , 2012, Journal of neurochemistry.

[14]  N. Cheung,et al.  Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. , 2012, Journal of Alzheimer's disease : JAD.

[15]  S. Itohara,et al.  Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the Hippocampus , 2011, The Journal of Neuroscience.

[16]  R. Jope,et al.  Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3 , 2011, International journal of Alzheimer's disease.

[17]  S. Feinstein,et al.  Amyloid β-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation* , 2011, The Journal of Biological Chemistry.

[18]  E. Tsilibary,et al.  Matrix metalloproteinase-9 participates in NGF-induced α-secretase cleavage of amyloid-β protein precursor in PC12 cells. , 2011, Journal of Alzheimer's disease : JAD.

[19]  M. Ohno,et al.  Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic mice , 2010, Journal of neurochemistry.

[20]  W. Markesbery,et al.  Neuron specific toxicity of oligomeric amyloid-β: role for JUN-kinase and oxidative stress. , 2010, Journal of Alzheimer's disease : JAD.

[21]  S. M. de la Monte,et al.  Insulin resistance and Alzheimer's disease. , 2009, BMB reports.

[22]  John Hardy,et al.  The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.

[23]  H. Vinters,et al.  β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.

[24]  W. Klein,et al.  Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers , 2009, Proceedings of the National Academy of Sciences.

[25]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[26]  Joseph Nunez,et al.  Primary Culture of Hippocampal Neurons from P0 Newborn Rats , 2008, Journal of visualized experiments : JoVE.

[27]  Hollis T. Cline,et al.  Insulin Receptor Signaling Regulates Synapse Number, Dendritic Plasticity, and Circuit Function In Vivo , 2008, Neuron.

[28]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[29]  Lorraine Lau,et al.  MMPs in the central nervous system: where the good guys go bad. , 2008, Seminars in cell & developmental biology.

[30]  W. Klein,et al.  Amyloid beta oligomers induce impairment of neuronal insulin receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  E. Tsilibary,et al.  Abeta(1–40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP , 2007, Neurobiology of Disease.

[32]  D. Ethell,et al.  Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets , 2007, Journal of neuroscience research.

[33]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[34]  M. Korte,et al.  The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice , 2007, The Journal of Neuroscience.

[35]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[36]  J. Lucas,et al.  A mouse model to study tau pathology related with tau phosphorylation and assembly , 2007, Journal of the Neurological Sciences.

[37]  L. Kaczmarek,et al.  Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction , 2007, Cell Death and Differentiation.

[38]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[39]  F. LaFerla,et al.  Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.

[40]  W. Klein,et al.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  M. Korte,et al.  The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  Kimberly Scearce-Levie,et al.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. , 2007, The Journal of biological chemistry.

[43]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[44]  Jin-Moo Lee,et al.  Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ* , 2006, Journal of Biological Chemistry.

[45]  J. Hwang,et al.  Activation of the Trk Signaling Pathway by Extracellular Zinc , 2005, Journal of Biological Chemistry.

[46]  Rémi Quirion,et al.  Comparative signaling pathways of insulin‐like growth factor‐1 and brain‐derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival , 2004, Journal of neurochemistry.

[47]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[49]  D. Flood,et al.  Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition , 2002, The Journal of Neuroscience.

[50]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[51]  Xiongwei Zhu,et al.  Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.

[52]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[53]  T. Ikeuchi,et al.  Insulin Receptor Substrate (IRS)-1 and IRS-2 Are Tyrosine-phosphorylated and Associated with Phosphatidylinositol 3-Kinase in Response to Brain-derived Neurotrophic Factor in Cultured Cerebral Cortical Neurons* , 1997, The Journal of Biological Chemistry.

[54]  Michael J. Cullen,et al.  Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40) , 1996, The Journal of Neuroscience.